Global ELISA Technologies Market Research Report 2023

Publication ID:

PB503237756

Publication Date:

March 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples鈥攕erum, plasma, cell culture supernatants and cell lysates鈥攊ndicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Highlights
The global ELISA Technologies market was valued at US$ 186.4 million in 2022 and is anticipated to reach US$ 230.5 million by 2029, witnessing a CAGR of 3.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ELISA Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ELISA Technologies.
The ELISA Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ELISA Technologies market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ELISA Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
American Laboratory Products Company (ALPCO)
BD Biosciences
BioM茅rieux SA
Bio-Rad Laboratories
EMD Millipore Corp
Life Technologies Corporation
Ortho-Clinical Diagnostics
R&D Systems
Thermo Fisher Scientific
ZEUS Scientific
Segment by Type
Sandwich ELISA
Indirect ELISA
Multiple and portable ELISA
Segment by Application
Academia
Blood Banks
Hospitals
Pharma & Biotechnology Companies
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ELISA Technologies companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ELISA Technologies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sandwich ELISA
1.2.3 Indirect ELISA
1.2.4 Multiple and portable ELISA
1.3 Market by Application
1.3.1 Global ELISA Technologies Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academia
1.3.3 Blood Banks
1.3.4 Hospitals
1.3.5 Pharma & Biotechnology Companies
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ELISA Technologies Market Perspective (2018-2029)
2.2 ELISA Technologies Growth Trends by Region
2.2.1 Global ELISA Technologies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 ELISA Technologies Historic Market Size by Region (2018-2023)
2.2.3 ELISA Technologies Forecasted Market Size by Region (2024-2029)
2.3 ELISA Technologies Market Dynamics
2.3.1 ELISA Technologies Industry Trends
2.3.2 ELISA Technologies Market Drivers
2.3.3 ELISA Technologies Market Challenges
2.3.4 ELISA Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ELISA Technologies Players by Revenue
3.1.1 Global Top ELISA Technologies Players by Revenue (2018-2023)
3.1.2 Global ELISA Technologies Revenue Market Share by Players (2018-2023)
3.2 Global ELISA Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ELISA Technologies Revenue
3.4 Global ELISA Technologies Market Concentration Ratio
3.4.1 Global ELISA Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ELISA Technologies Revenue in 2022
3.5 ELISA Technologies Key Players Head office and Area Served
3.6 Key Players ELISA Technologies Product Solution and Service
3.7 Date of Enter into ELISA Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ELISA Technologies Breakdown Data by Type
4.1 Global ELISA Technologies Historic Market Size by Type (2018-2023)
4.2 Global ELISA Technologies Forecasted Market Size by Type (2024-2029)
5 ELISA Technologies Breakdown Data by Application
5.1 Global ELISA Technologies Historic Market Size by Application (2018-2023)
5.2 Global ELISA Technologies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America ELISA Technologies Market Size (2018-2029)
6.2 North America ELISA Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America ELISA Technologies Market Size by Country (2018-2023)
6.4 North America ELISA Technologies Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ELISA Technologies Market Size (2018-2029)
7.2 Europe ELISA Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe ELISA Technologies Market Size by Country (2018-2023)
7.4 Europe ELISA Technologies Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ELISA Technologies Market Size (2018-2029)
8.2 Asia-Pacific ELISA Technologies Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific ELISA Technologies Market Size by Region (2018-2023)
8.4 Asia-Pacific ELISA Technologies Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ELISA Technologies Market Size (2018-2029)
9.2 Latin America ELISA Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America ELISA Technologies Market Size by Country (2018-2023)
9.4 Latin America ELISA Technologies Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ELISA Technologies Market Size (2018-2029)
10.2 Middle East & Africa ELISA Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa ELISA Technologies Market Size by Country (2018-2023)
10.4 Middle East & Africa ELISA Technologies Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 American Laboratory Products Company (ALPCO)
11.1.1 American Laboratory Products Company (ALPCO) Company Detail
11.1.2 American Laboratory Products Company (ALPCO) Business Overview
11.1.3 American Laboratory Products Company (ALPCO) ELISA Technologies Introduction
11.1.4 American Laboratory Products Company (ALPCO) Revenue in ELISA Technologies Business (2018-2023)
11.1.5 American Laboratory Products Company (ALPCO) Recent Development
11.2 BD Biosciences
11.2.1 BD Biosciences Company Detail
11.2.2 BD Biosciences Business Overview
11.2.3 BD Biosciences ELISA Technologies Introduction
11.2.4 BD Biosciences Revenue in ELISA Technologies Business (2018-2023)
11.2.5 BD Biosciences Recent Development
11.3 BioM茅rieux SA
11.3.1 BioM茅rieux SA Company Detail
11.3.2 BioM茅rieux SA Business Overview
11.3.3 BioM茅rieux SA ELISA Technologies Introduction
11.3.4 BioM茅rieux SA Revenue in ELISA Technologies Business (2018-2023)
11.3.5 BioM茅rieux SA Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories ELISA Technologies Introduction
11.4.4 Bio-Rad Laboratories Revenue in ELISA Technologies Business (2018-2023)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 EMD Millipore Corp
11.5.1 EMD Millipore Corp Company Detail
11.5.2 EMD Millipore Corp Business Overview
11.5.3 EMD Millipore Corp ELISA Technologies Introduction
11.5.4 EMD Millipore Corp Revenue in ELISA Technologies Business (2018-2023)
11.5.5 EMD Millipore Corp Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Detail
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation ELISA Technologies Introduction
11.6.4 Life Technologies Corporation Revenue in ELISA Technologies Business (2018-2023)
11.6.5 Life Technologies Corporation Recent Development
11.7 Ortho-Clinical Diagnostics
11.7.1 Ortho-Clinical Diagnostics Company Detail
11.7.2 Ortho-Clinical Diagnostics Business Overview
11.7.3 Ortho-Clinical Diagnostics ELISA Technologies Introduction
11.7.4 Ortho-Clinical Diagnostics Revenue in ELISA Technologies Business (2018-2023)
11.7.5 Ortho-Clinical Diagnostics Recent Development
11.8 R&D Systems
11.8.1 R&D Systems Company Detail
11.8.2 R&D Systems Business Overview
11.8.3 R&D Systems ELISA Technologies Introduction
11.8.4 R&D Systems Revenue in ELISA Technologies Business (2018-2023)
11.8.5 R&D Systems Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific ELISA Technologies Introduction
11.9.4 Thermo Fisher Scientific Revenue in ELISA Technologies Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 ZEUS Scientific
11.10.1 ZEUS Scientific Company Detail
11.10.2 ZEUS Scientific Business Overview
11.10.3 ZEUS Scientific ELISA Technologies Introduction
11.10.4 ZEUS Scientific Revenue in ELISA Technologies Business (2018-2023)
11.10.5 ZEUS Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

American Laboratory Products Company (ALPCO)
BD Biosciences
BioM茅rieux SA
Bio-Rad Laboratories
EMD Millipore Corp
Life Technologies Corporation
Ortho-Clinical Diagnostics
R&D Systems
Thermo Fisher Scientific
ZEUS Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂